Drug Screening Identifies Sigma-1-Receptor as a Target for the Therapy of VWM Leukodystrophy

Overview of attention for article published in Frontiers in Molecular Neuroscience, September 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (70th percentile)
Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

twitter: 4 X users
facebook: 1 Facebook page

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 20 Dimensions

Readers on

mendeley: 24 Mendeley

Summary X Facebook Wikipedia Dimensions citations

So far, Altmetric has seen 6 X posts from 4 X users, with an upper bound of 78,405 followers.

RT @LifeSciHealthIL: Drug Screening Identifies Sigma-1-Receptor as a Target for the Therapy of VWM Leukodystrophy https://t.co/9RytCIrlLo #…

29 Dec 2018

Reply Repost Favourite

RT @FrontNeurosci: Drug Screening Identifies Sigma-1-Receptor as a Target for the Therapy of VWM Leukodystrophy: Andrea Atzmon, Melisa Herr…

01 Nov 2018

Reply Repost Favourite

#vwm #prehealthbrockville #interesting https://t.co/6i7CZTJjmT

19 Oct 2018

Reply Repost Favourite

Drug Screening Identifies Sigma-1-Receptor as a Target for the Therapy of VWM Leukodystrophy: Andrea Atzmon, Melisa Herrero, Reut Sharet-Eshed, Yocheved Gilad, Hanoch Senderowitz, Orna Elroy-Stein https://t.co/PocQfQRSfx

28 Sep 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.